Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$2.07 - $2.83 $8,878 - $12,137
-4,289 Reduced 38.26%
6,921 $17,000
Q1 2024

May 10, 2024

SELL
$2.18 - $3.58 $38,272 - $62,850
-17,556 Reduced 61.03%
11,210 $32,000
Q4 2023

Feb 12, 2024

SELL
$1.71 - $2.57 $29,497 - $44,332
-17,250 Reduced 37.49%
28,766 $66,000
Q3 2023

Nov 14, 2023

SELL
$2.51 - $3.55 $19,665 - $27,814
-7,835 Reduced 14.55%
46,016 $120,000
Q2 2023

Aug 11, 2023

SELL
$2.12 - $4.47 $254,974 - $537,611
-120,271 Reduced 69.07%
53,851 $192,000
Q1 2023

May 11, 2023

SELL
$1.93 - $13.1 $444,855 - $3.02 Million
-230,495 Reduced 56.97%
174,122 $379,000
Q4 2022

Feb 13, 2023

BUY
$5.88 - $12.03 $705,682 - $1.44 Million
120,014 Added 42.17%
404,617 $4.87 Million
Q3 2022

Nov 14, 2022

SELL
$4.6 - $9.91 $238,951 - $514,784
-51,946 Reduced 15.43%
284,603 $1.84 Million
Q2 2022

Aug 11, 2022

BUY
$3.72 - $9.0 $1.19 Million - $2.87 Million
318,801 Added 1796.26%
336,549 $1.54 Million
Q1 2022

May 11, 2022

SELL
$8.19 - $13.89 $140,941 - $239,033
-17,209 Reduced 49.23%
17,748 $153,000
Q4 2021

Feb 10, 2022

BUY
$12.98 - $29.75 $308,262 - $706,532
23,749 Added 211.89%
34,957 $499,000
Q3 2021

Nov 12, 2021

BUY
$12.13 - $23.82 $135,953 - $266,974
11,208 New
11,208 $246,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.